Latest Posts

16 May 2019

MAY 19: Deductible Relief Day

Deductible Relief Day is May 19. That’s the date by which average spending for people with employer-sponsored health insurance is sufficient to satisfy the average deductible, the amount they must pay out-of-pocket for most health care services before their insurance plan kicks in to help pay the bills, Kaiser Family

0
09 May 2019

Velano Draws $10M Growth Funding for Needle-Free Blood Collection Technology

    By Amanda Pedersen A company trying to transform blood collection with its needle-free technology has attracted the attention of several notable medtech entrepreneurs and investors. Velano Vascular has secured $10 million as the initial tranche of a growth financing to fuel commercialization and the launch of new vascular

0
09 May 2019

Government policy shift prompts Medtronic to bail on bundled knees; Responsive Orthopedics for sale

After three years in the bundled joint replacement business, a federal policy shift is prompting Medtronic to put its Responsive Orthopedics business on the auction block. The May 2016 acquisition of Minneapolis-based Responsive for an undisclosed amount put Medtronic in line for a bundled joint replacement program piloted by the Centers for Medicare & Medicaid Services. The 5-year “Comprehensive

0
09 May 2019

3D printing innovation allows scientists to create vascular network

  By Jade Boyd Bioengineers have cleared a major hurdle on the path to 3D printing replacement organs with a breakthrough technique for bioprinting tissues. The new innovation allows scientists to create exquisitely entangled vascular networks that mimic the body’s natural passageways for blood, air, lymph and other vital fluids.

0
08 May 2019

DRUG INDUSTRY PATENTS GO UNDER SENATE JUDICIARY COMMITTEE’S MICROSCOPE

By Rachel Bluth   Congress isn’t making much headway in finding a solution to the problem of soaring prescription drug prices, but lawmakers from both parties are tinkering on the edges with legislation that aims to increase competition among drugmakers. A comprehensive piece of drug-pricing legislation is a high priority for

0
SHARE

Home